Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Chordate presents study results for the American Headache Society

The final results from Chordate Medical’s PM007 study show that K.O.S. has a significant effect for the preventive treatment of chronic migraine. The results will be presented at the American Headache Society Scientific Meeting in mid-June and are also available on the organisation’s website.Read the full article at biostock.se: https://www.biostock.se/en/2023/04/chordate-presents-study-results-for-the-american-headache-society/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Clinical Laserthermia Systems Announces Agreement with AVANT Concierge Urology to Treat Prostate Cancer Patients with TRANBERG Thermal Therapy System

Lund, Sweden – April 19, 2023 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announces that their US subsidiary CLS Americas has signed a Mobile Service Provider (MSP) Agreement with AVANT Concierge Urology  of Winterhaven, FL.Under the agreement, AVANT will begin using the CLS TRANBERG Thermal Therapy System  to treat patients with early-intermediate stage prostate cancer. According to the agreement, CLS provides its 510(k) cleared TRANBERG Thermal Therapy System, with consumable accessories,

Fazer includes food loss as a metric in its 2023 Short-Term Incentive plan

Fazer’s Board of Directors has decided to broaden the ESG (Environmental, Social, and Governance) criteria in the company’s Short-Term Incentive plan (STI), and to include food loss as a metric, in addition to Employee Safety, which has long been an ESG priority for Fazer. The portion of the ESG basket in the 2023 STI plan amounts to 15% of the total, highlighting the importance of ESG to the Group. The remainder of the annual STI performance criteria include Group and Business Area financial performance related goals.Food loss has a major impact on climate, water, land and biodiversity.

Observit AB publishes stock analysis from Carlsquare and summons to an extraordinary General meeting ahead of listing.

Carlsquare has published a stock analysis regarding Observit AB, which was distributed to SpectrumOne’s shareholders during July 2022. SpectrumOne still holds 16,7 % of the shares in Observit AB. In the analysis, Carlsquare points to a share price between SEK 0.28 – 0.48/share in a base and a bull scenario respectively. Furthermore, Observit AB has summoned to an extraordinary General meeting to elect Thomas Jönsson and Johan Lembre as new board members. Johan Lembre is CTO at the lighting company Fagerhult Group and before that Johan was CEO at the Swedish headphone company Earin. He

Katalysen portfolio company InvitePeople reports strong progress in German market

Katalysen Ventures is excited to announce that portfolio company and event-tech leader InvitePeople has entered the DACH region, with the aim to replicate its Nordic-market success in the ten times larger German-speaking European market.InvitePeople, the virtual platform for true digital and hybrid events and meetings, has formally entered the large German-speaking European market by acquiring a Berlin-based company with about 10 employees. This Berlin-based company has now been transformed from its previous event-related business to become the foundation for InvitePeople Germany, selling

NOTE’s Interim Report January–March 2023

Financial performance January–March• Sales increased by 28% to SEK 1,051 (821) million. Adjusted for acquisitions and currency effects, organic growth was 14%.• Operating profit increased by 48% to SEK 112 (76) million.• The operating margin widened by 1.4 percentage points to 10.7% (9.3%).• Profit after financial items was up by 50% to SEK 104 (69) million.• Profit after tax rose by 51% to SEK 85 (56) million, corresponding to SEK 2.92 (1.95) per share.• Cash flow after investments amounted to SEK 49 (9) million, or SEK 1.69 (0.31) per share. Adjusted for acquisition-related

Invitation to presentation of BioArctic’s first quarter report for January - March 2023 on April 27 at 9.30 a.m. CET

Stockholm, Sweden, April 19, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company’s first quarter report for January – March 2023 on Thursday, April 27, 2023, at 08:00 a.m. CET.In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on April 27, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the first quarter report for January – March 2023, followed by a Q&A-session. If you wish to participate via webcast, please use the link below.

Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)

N.B. This English text is an unofficial translation of the Swedish original of the notice to attend the annual general meeting. In case of any discrepancies between the Swedish and English language versions, the Swedish version shall prevail. April 19 2023 – Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820 (the “Company”), are hereby summoned to the Annual General Meeting on Wednesday May 24, 2023 at 17.00 (CET) at Setterwalls Advokatbyrå’s offices at Sturegatan 10 in Stockholm. Registration for the meeting commences at 16.30 (CET).NoticeShareholders wishing to

Scania and Northvolt unveil green battery capable of powering trucks for 1.5 million kilometers

Today, Scania and Northvolt unveiled a jointly developed battery cell for heavy electric vehicles. In validation tests, the lithium-ion cell has demonstrated an outstanding lifetime resulting in the capacity to power trucks for 1.5 million kilometers – equivalent to the truck's whole lifetime. Produced with fossil-free electricity in northern Sweden, the cell’s carbon footprint is approximately one-third that of a comparative industry reference.In 2017, sustainability frontrunners Scania and Northvolt joined forces to develop and commercialize a world-leading battery cell for heavy

CGit AB changes name to Aixia AB

Mölndal                                                                                     2023-04-19 CGit AB changes name to Aixia AB Aixia AB, formerly known as CGit AB, announces today that the company has changed its name. The new name takes effect immediately. "The name change reflects our strategic focus on developing and delivering innovative solutions that contribute to our continued growth and success." says CEO Mattias Bergkvist. "It is a statement about the company's great potential in tomorrow's IT infrastructure and AI, but also an identity that stands out in the

NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTERVACC AB (PUBL)

The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Extraordinary General Meeting (“EGM”) to be held on Friday 5 May 2023 at 10.00 a.m. at Good Morning Hotel, Västertorpsvägen 131, in Hägersten. The Board of Directors has resolved that shareholders shall have the right to exercise their voting rights in advance through postal voting pursuant to Chapter 7, Section 4 a of the Swedish Companies Act and the Company’s Articles of Associations. Therefore, shareholders may choose to exercise their voting rights at the EGM by attending by

ABGSC to publish Q1 2023 Interim Report on 26 April

ABG Sundal Collier (“ABGSC”) will publish its Q1 2023 figures on 26 April 2023 at 08:00 CEST. The report will be available on our corporate website www.abgsc.com. Webcast presentation CEO Jonas Ström will present the Q1 result through a webcast at 09:00 CEST, followed by a Q&A session. The webcast presentation can be accessed through a web link or call-in details presented on our corporate website www.abgsc.com. For further information: Geir B. Olsen, CFO, +47 22 01 60 35 For media contacts: Anna Tropp, Head of Communications, +46 722 30 94 17

Diaverum welcomes M42 as its new shareholder

Diaverum is announcing today that M42 has entered into a definitive agreement to acquire 100% of the company from Bridgepoint.Diaverum, acquired by Bridgepoint in 2007, is a leading global renal care company that provides essential, life-sustaining dialysis treatments to patients in around 440 clinics across 23 countries worldwide. The company’s main focus is haemodialysis, in conjunction with a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to the coordination of patients’ comorbidities and their preparation for kidney transplantation. Diaverum

Esmaeilzadeh Holding publishes net asset value as of 31 March 2023

As of 31 March 2023, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 7.59 billion (SEK 7.62 billion as of 28 February 2023), corresponding to a net asset value per share of SEK 9,848 (SEK 9,886 as of 28 February 2023). For further information, please contact: Saeid Esmaeilzadeh, CEO and founder +46 707 18 70 61, saeid@ehab.group Nils Fredrik Lagerstrand, General Counsel & Deputy CEO +46 720 90 26 99, nilsfredrik@ehab.group The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on 19 April 2023.

Lytix Biopharma appoints new Chairman of the Board

Oslo, Norway, April 18, 2023 – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces the election of a new Chairman of the Board at today’s General Assembly. The new Chairman is Dr Marie Roskrow, a senior executive with international experience in both lifesciences and investment banking.Dr Roskrow holds a medical degree and a PhD in Immunology and serves currently as the Chairman of a number of international biotechnology companies. “I’m very excited that Marie Roskrow is joining Lytix as the new Chairman of our board. Marie has

Notice to attend the Annual General Meeting of Bricknode Holding AB (publ)

Shareholders in Bricknode Holding AB (publ), Reg. No 559083-5970 ("Bricknode" or the "Company"), are hereby given notice of the Annual General Meeting to be held on Wednesday, 17 May 2023 at 09:00 CEST at Lögegatan 11 in Skövde.Information about the decisions made during the Annual General Meeting will be published on 17 May 2023, as soon as the outcome of the postal voting has been compiled. Right to participate and notice of participation A person who wishes to participate in the Meeting, through postal voting, must be listed in the shareholder register prepared by Euroclear Sweden

Mycronic receives order for an SLX mask writer

Mycronic AB (publ) has received an order for an SLX mask writer from an existing customer in Asia. The order value is in the range of USD 5-7 million. Delivery of the system is planned for the first quarter of 2025.The SLX laser mask writer meets rising demand for photomasks for the semiconductor industry and a future need for replacement and modernization. Photomasks manufactured by laser mask writers are of high importance and account for a majority of all photomasks produced for semiconductor manufacturing. SLX is a modern and energy efficient mask writer based on the same technology as

Aker Carbon Capture awarded test campaign and study for Fortum Waste Solutions in Denmark

Aker Carbon Capture has been awarded a test campaign and feasibility study for Fortum Waste Solutions’ facility in Nyborg, Denmark. Fortum’s waste incineration plant is specialized in the safe destruction of hazardous waste and turning it into energy. The planned capture capacity will be around 170,000 tonnes CO2/year.Aker Carbon Capture is currently delivering a first-of-a-kind modular carbon capture facility at Twence’s waste-to-energy plant in Hengelo, the Netherlands. The company will bring learnings from this project to the Fortum decarbonization study.   “We are proud to be working

Bexmarilimab KOL Event

Faron Pharmaceuticals Oy   ("Faron or the Company")   Bexmarilimab for Hematological Malignancies KOL Event   Press Release, April 19, 2023   TURKU, FINLAND / BOSTON, MA -  Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON),  a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces plans to host a virtual KOL event via webcast on Tuesday, April 25 at 11.00 EST/16.00 BST/18.00 EEST with Dr. Naval Daver, MD, Associate Professor of Leukemia at The University of Texas MD Anderson Cancer Center; Dr. Mika

The Board of Directors in Intervacc intends to resolve on a fully covered rights issue of approximately SEK 100 million

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, RELEASE OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE PURSUANT TO APPLICABLE LAW. PLEASE REFER TO OMPIRTANT INFORMATION AT THE END OF THE PRESS RELEASE. Stockholm, April 19, 2023 The Board of Directors of Intervacc AB (publ) (“Intervacc” or

Viaplay Group and Deutsche Telekom’s MagentaTV enter Viaplay Select partnership

· Agreement is the first for Viaplay Select in Germany · More than 300 hours of premium Viaplay Select content available on Deutsche Telekom’s MagentaTV service · Line-up includes acclaimed titles such as ‘Cell 8’, ‘Fenris’, ‘The Truth Will Out’ and Canneseries nominee ‘The Dreamer – Becoming Karen Blixen’ Viaplay Group and Deutsche Telekom, Europe’s largest telecom operator, have agreed a partnership that brings Viaplay Select’s premium content to Deutsche Telekom’s MagentaTV service in Germany. Viewers can access over 300 hours of Viaplay’s most acclaimed series, films and

Increase in rental income mitigates impact of higher financing costs

· Rental income increased to SEK 350 million (311) · Income from property management amounted to SEK 161 million (173) · Profit for the period amounted to SEK 78 million (1,382) · Value of property portfolio amounted to SEK 27,387 million (26,994) · Earnings per share totalled SEK 0.65 (11.53) · Strong net lettings and large number of new leases · Sustainable financial model and daily improvements provide stability in an uncertain market · Reduced energy consumption and steps to increase recycling · Merkurhuset wins Kasper Salin Prize for best building in Sweden ·

Stayble Therapeutics AB appoints Jarkko Kalliomäki as Chief Medical Officer

Stayble Therapeutics AB (”Stayble” or ”the Company”) today announces that Jarkko Kalliomäki will assume the role of Chief Medical Officer (CMO) in the Company. Jarkko Kalliomäki is a specialist physician in rehabilitation and pain management and a medical doctor in physiology. He has over ten years of experience in the pharmaceutical industry in a number of pain-related projects and works as a senior physician in rehabilitation medicine and pain management at, among others, Lunds Universitetssjukhus Sophiahemmet and Capio S:t Göran's hospital, Stockholm."With Jarkko as CMO, Stayble gains an

MapsPeople to acquire activities from Point Inside Inc.

MapsPeople A/S | Inside information Company Announcement No.  11-2023 Aalborg, April 19, 2023MapsPeople A/S (MapsPeople) has reached an agreement to acquire all of US based Point Inside's, Inc (Point Inside) customer contracts and indoor mapping assets in an acquisition where MapsPeople will acquire the activities and assets from Point Inside. All investors of Point Inside will become shareholders in MapsPeople. With the acquisition of the Point Inside business, MapsPeople gains a roster of high-profile global brands. The indoor mapping assets from Point Inside include indoor maps

There are no items matching the current filter
There are no more items matching the current filter
Back to top